Article
Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 2 Aug 2022
Bukowski Alexandra, Hoyo Cathrine, Hudgens Michael G, Brewster Wendy R, Valea Fidel, Bentley Rex C, Vidal Adriana C, Maguire Rachel L, Schmitt John W, Murphy Susan K, North Kari E, Smith Jennifer S
Abstract excerpt
BACKGROUND: High-risk human papillomavirus (hrHPV) testing is utilized in primary cervical cancer screening, generally along with cytology, to triage abnormalities to colposcopy. Most screening-based hrHPV testing involves pooled detection of any hrHPV or of HPV16/18. Cervical neoplasia progressi...
Topics
- Adult
- Early Detection of Cancer
- Female
- Genotype
- Human papillomavirus 16
- Human papillomavirus 18
- Humans
- Papillomaviridae
- Papillomavirus Infections
- Prospective Studies
- Uterine Cervical Neoplasms